| 12318374 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2025-06-03 |
|
| 12226406 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2025-02-18 |
|
| 12213967 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2025-02-04 |
|
| 12213968 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2025-02-04 |
|
| 12064422 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2024-08-20 |
|
| 12023328 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2024-07-02 |
|
| 11969415 |
(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2024-04-30 |
|
| 11918564 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2024-03-05 |
|
| 11911370 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2024-02-27 |
|
| 11903933 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2024-02-20 |
|
| 11896585 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2024-02-13 |
|
| 11850241 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2023-12-26 |
|
| 11850240 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2023-12-26 |
|
| 11844788 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2023-12-19 |
|
| 11801237 |
Amorphous kinase inhibitor formulations and methods of use thereof |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2023-10-31 |
|
| 11793795 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2023-10-24 |
|
| 11612591 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2023-03-28 |
|
| 11576903 |
Amorphous kinase inhibitor formulations and methods of use thereof |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2023-02-14 |
|
| 11395818 |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2022-07-26 |
$20,205,000 |
| 11266614 |
Oral formulations of belinostat |
Perrine Pivette, Caroline Lemarchand, Ian Yates |
2022-03-08 |
|
| 11185535 |
Amorphous kinase inhibitor formulations and methods of use thereof |
Michael D. Kaufman, Scott Bone, Fred Jordan |
2021-11-30 |
$10,356,000 |
| 11185544 |
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same |
Anthony Chris Garland, Barbara-Jean Anne Bormann-Kennedy, Bomi Framroze, Bret Berner, Michael Grass +3 more |
2021-11-30 |
|
| 9757464 |
Pharmaceutical compositions of dextran polymer derivatives |
Warren K. Miller, David T. Vodak, Daniel E. Dobry, David K. Lyon, Dwayne T. Friesen +2 more |
2017-09-12 |
|
| 9457093 |
Solid dispersions of a ERB2 (HER2) inhibitor |
David Shank Fry, Christopher M. Lindemann, Michael Preigh, Christopher Donovan Craig, Devon Brevard Dubose +2 more |
2016-10-04 |
$24,087,000 |
| 9233078 |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer |
Marshall Crew, Warren K. Miller |
2016-01-12 |
|